EP3283527
SAMSETT MEÐFERÐ VIÐ KRABBAMEINI
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
12.4.2016EP published:
13.1.2021EP application number:
16718802.8
EP translation filed:
1.3.2021Grant published:
15.3.2021EPO information:
European Patent Register
Max expiry date:
11.4.2036Expiry date:
11.4.2025
Title:
COMBINATION THERAPY FOR CANCER
Timeline
Today
12.4.2016EP application
13.1.2021EP Publication
1.3.2021Translation submitted
15.3.2021Registration published
11.4.2025Expires
Owner
Name:
Five Prime Therapeutics, Inc.Address:
111 Oyster Point Boulevard, South San Francisco, CA 94080, US
Inventor
Name:
MASTELLER, EmmaAddress:
South San Francisco, California 94080, US
Name:
BRENNAN, ThomasAddress:
South San Francisco, California 94080, US
Name:
BELLOVIN, DavidAddress:
South San Francisco, California 94080, US
Name:
BAKER, KevinAddress:
South San Francisco, California 94080, US
Name:
WONG, BrianAddress:
South San Francisco, California 94080, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201562146766 PDate:
13.4.2015Country:
US
Number:
201562190945 PDate:
10.7.2015Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 15.2.2021
Expires: 11.4.2022
Payer: G.H. Sigurgeirsson ehf.
Number: 7
Paid: 10.3.2022
Expires: 11.4.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.3.2023
Expires: 11.4.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.3.2024
Expires: 11.4.2025
Payer: Árnason Faktor ehf.